---
id: strategic-growth-roadmap
title: Strategic Growth Roadmap
category: executive_prompts
author: Frederick de Ruiter
created: 2025-07-18
last_modified: 2025-07-18
tested_model: gpt-4o
temperature: 0.2
tags: [executive, growth]
---

# Strategic Growth Roadmap

## Purpose

Rank therapeutic areas for expansion over the next three years.

## Context

You are a senior life-sciences market-intelligence analyst. Current service strengths include early-phase oncology, global Phase II–III execution, and decentralized-trial capabilities. Target geographies are APAC (Japan, South Korea) and LATAM (Brazil, Mexico). Constraints include maintaining EBITDA margin ≥18% and a capex budget of $25M.

## Instructions

- Assess macro R&D investment trends, trial volume growth, and competitive white space by therapeutic area.
- Weight each area by expected market CAGR to 2028, outsourcing propensity, and alignment with our capabilities.
- Draft a prioritized table ranking the top five areas with opportunity score, rationale (≤60 words), and estimated incremental revenue using the format:

  | Rank | Therapeutic area | Opportunity score (1-100) | 3-line rationale | 2025-2028 revenue ($M) |
  | --- | --- | --- | --- | --- |

- Conclude with two “no-go” areas and why.
- Cite 3–5 recent industry sources (title, publisher, date) in APA style.

## Inputs

- `{{industry_reports}}` – optional references or market data.

## Output Format

Markdown table and a brief notes section.

## Additional Notes

Use an executive tone and keep the response concise.
